Carbamic Acid

Carbamic Acid

SCHEMBL1013202

NC(=O)O.O=C(O)Nc1ccccc1C(F)(F)F

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.58
GAA P10253 1/20 0.56
GRIN2D O15399 1/20 0.55
GRIN3B O60391 1/20 0.55
GRIN1 Q05586 1/20 0.55
GRIN2A Q12879 1/20 0.55
GRIN2B Q13224 1/20 0.55
GRIN2C Q14957 1/20 0.55
GRIN3A Q8TCU5 1/20 0.55
SIGMAR1 Q99720 1/20 0.55
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
KDM4E B2RXH2 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
ALDH1A1 P00352 6/20 0.52
TSHR P16473 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
MAPK1 P28482 1/20 0.51
NPC1 O15118 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1008398 0.94 POLB (0.63) POLBGAAMEN1KMT2AKDM4E
SCHEMBL29958946 0.87 GRIN2D (0.60) POLBGAAGRIN2DGRIN3BGRIN1
SCHEMBL167598 0.87 GRIN2D (0.60) POLBGAAGRIN2DGRIN3BGRIN1
Trifluoroacetic Acid SCHEMBL7525892 0.84 CHIT1 (0.57) POLBGAAGRIN2DGRIN3BGRIN1
SCHEMBL30140772 0.82 GRIN2D (0.55) POLBGAAGRIN2DGRIN3BGRIN1
SCHEMBL5103394 0.81 POLB (0.49) POLBGAAMEN1KMT2AKDM4E
SCHEMBL2095028 0.80 POLB (0.47) POLBGAAMEN1KMT2AKDM4E
SCHEMBL1847415 0.80 EPHX2 (0.58) POLBGAAMEN1KMT2AKDM4E
SCHEMBL20827124 0.80 POLB (0.59) POLBGAAMEN1KMT2AKDM4E
SCHEMBL3938038 0.79 POLB (0.58) POLBGAAGRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268623-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2011-01-05 EP disclosed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO disclosed